The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Plerixafor plus G-CSF (P+G) compared with G-CSF alone (G) for hematopoietic progenitor cell (HPC) mobilization in AL amyloidosis (AL).
Binod Dhakal
No relevant relationships to disclose
Christopher Sun Strouse
No relevant relationships to disclose
Carlos Arce-Lara
No relevant relationships to disclose
Anita D'souza
No relevant relationships to disclose
Jean Esselman
No relevant relationships to disclose
Daniel Eastwood
No relevant relationships to disclose
Marcelo C. Pasquini
No relevant relationships to disclose
Wael Saber
No relevant relationships to disclose
William R Drobyski
No relevant relationships to disclose
Parameswaran Hari
No relevant relationships to disclose
Mehdi Hamadani
No relevant relationships to disclose